Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 May 20:10:100244.
doi: 10.1016/j.resplu.2022.100244. eCollection 2022 Jun.

Impact of extracorporeal CPR with transcatheter heart pump support (ECPELLA) on improvement of short-term survival and neurological outcome in patients with refractory cardiac arrest - A single-site retrospective cohort study

Takashi Unoki  1 , Motoko Kamentani  1 , Tomoko Nakayama  1 , Yudai Tamura  1 , Yutaka Konami  1 , Hiroto Suzuyama  1 , Masayuki Inoue  1 , Megumi Yamamuro  1 , Eiji Taguchi  1 , Tadashi Sawamura  1 , Koichi Nakao  1 , Tomohiro Sakamoto  1
Affiliations

Impact of extracorporeal CPR with transcatheter heart pump support (ECPELLA) on improvement of short-term survival and neurological outcome in patients with refractory cardiac arrest - A single-site retrospective cohort study

Takashi Unoki et al. Resusc Plus. .

Abstract

Aim: Extracorporeal cardiopulmonary resuscitation (E-CPR) using veno-arterial extracorporeal membrane oxygenation (VA-ECMO) is a novel lifesaving method for refractory cardiac arrest. Although VA-ECMO preserves end-organ perfusion, it may affect left ventricular (LV) recovery due to increased LV load. An emerging treatment modality, ECPELLA, which combines VA-ECMO and a transcatheter heart pump, Impella, can simultaneously provide circulatory support and LV unloading. In this single-site cohort study, we assessed impact of ECPELLA support on clinical outcomes of refractory cardiac arrest patients.

Method: We retrospectively reviewed 165 consecutive cardiac arrest patients, who underwent E-CPR by VA-ECMO with or without intra-aortic balloon pump (IABP) or ECPELLA from January 2012 to September 2021. We assessed 30-day survival rate, neurological outcome, hemodynamic data, and safety profiles including hemolysis, acute kidney injury, blood transfusion and embolic cerebral infarction.

Results: Among 165 E-CPR patients, 35 patients were supported by ECPELLA, and 130 patients were supported by conventional VA-ECMO with or without IABP. Following propensity score matching of 30 ECPELLA and 30 VA-ECMO patients, the 30-day survival (ECPELLA: 53%, VA-ECMO: 20%, p < 0.01) and favorable neurological outcome determined by the Cerebral Performance Category score 1 or 2 (ECPELLA: 33%, VA-ECMO: 7%, p < 0.01) were significantly higher with ECPELLA. Patients receiving ECPELLA also showed significantly higher total mechanical circulatory support flow and lower arterial pulse pressure for the first 3 days (p < 0.01) of treatment. There were no statistical differences in safety profiles between treatment groups.

Conclusion: ECPELLA may be associated with improved 30-day survival and neurological outcome in patients with refractory cardiac arrest.

Keywords: ANOVA, Analysis of variance; CI, Confidential interval; CPC, Cerebral Performance Categories; CPR, Cardiopulmonary resuscitation; CVP, Central venous pressure; Cardiac arrest; Circulatory support; E-CPR, Extracorporeal cardiopulmonary resuscitation; ECPELLA, Combination of VA-ECMO and Impella transcatheter heart pump support; Extracorporeal cardiopulmonary resuscitation; IABP, Intra-aortic balloon pump; Impella; LV unloading; LV, Left ventricle; MCS, Mechanical circulatory support; Myocardial protection; OHCA, Out-of-hospital cardiac arrest; PAPI, Pulmonary artery pulsatility index; VA-ECMO, Venoarterial extracorporeal membrane oxygenation; VIS, Vasoactive inotrope score.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Patient enrollment flow chart. ACS: acute coronary syndrome, CPR: cardiopulmonary resuscitation, E-CPR: extracorporeal CPR, ECPELLA: Impella + VA-ECMO support, OHCA: out-of-hospital cardiac arrest, VA-ECMO: venoarterial extracorporeal membrane oxygenation.
Fig. 2
Fig. 2
Kaplan-Meier survival curve analysis and 30-day survival rate. 30-day survival of ECPELLA patients compared to patients receiving VA-ECMO (p < 0.01).
Fig. 3
Fig. 3
Total mechanical circulatory support (MCS) flow, and serum lactate levels. Panel A: Total MCS flows (*: p < 0.01 vs. VA-ECMO by Wilcoxon test); Panel B: Serum lactate levels with ECPELLA and VA-ECMO on day1 and day 3 (p < 0.01).
See this image and copyright information in PMC

References

    1. Panchal A.R., Berg K.M., Hirsch K.G., Kudenchuk P.J., del Rios M., Cabanãs J.G., et al. 2019 American Heart Association Focused Update on Advanced Cardiovascular Life Support: Use of Advanced Airways, Vasopressors, and Extracorporeal Cardiopulmonary Resuscitation during Cardiac Arrest: An Update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2019;140(24):e881–e894. doi: 10.1161/CIR.0000000000000732. - DOI - PubMed
    1. Rao P., Khalpey Z., Smith R., Burkhoff D., Kociol R.D. Venoarterial Extracorporeal Membrane Oxygenation for Cardiogenic Shock and Cardiac Arrest. Circ Heart Fail. 2018;11(9) doi: 10.1161/CIRCHEARTFAILURE.118.004905. - DOI - PubMed
    1. Klee T.E., Kern K.B. A review of ECMO for cardiac arrest. Resusc Plus. 2021;5:100083. doi: 10.1016/j.resplu.2021.100083. - DOI - PMC - PubMed
    1. Acharya D., Torabi M., Borgstrom M., Rajapreyar I., Lee K., Kern K., et al. Extracorporeal Membrane Oxygenation in Myocardial Infarction Complicated by Cardiogenic Shock: Analysis of the ELSO Registry. J Am Coll Cardiol. 2020;76(8):1001–1002. doi: 10.1016/j.jacc.2020.06.062. - DOI - PubMed
    1. Matsuyama T., Irisawa T., Yamada T., Hayakawa K., Yoshiya K., Noguchi K., et al. Impact of Low-Flow Duration on Favorable Neurological Outcomes of Extracorporeal Cardiopulmonary Resuscitation After Out-of-Hospital Cardiac Arrest. Circulation. 2020;141(12):1031–1033. doi: 10.1161/CIRCULATIONAHA.119.044285. - DOI - PubMed

LinkOut - more resources